1.
Bio Vascular Inc. Arterial Venous Grafts
Placement of the AV graft in the canine model. The letter designations depict the position of the section with respect to the AV graft placement. ...
2.
Bio Vascular Inc. Endovascular Procedures
Endovascular Procedures. The effect of Saratin on the endovascular healing of surgically-injured vessels was studied in rats. In this model, saratin was ...
3.
Bio Vascular Inc. Arterial Venous Grafts
Four weeks after surgery the animals were sacrificed and the degree of intimal hyperplasia at the venous anastomosis – the usual site of graft failure in ...
4.
Bio Vascular Inc. Arterial Venous Grafts
Placement of the AV graft in the canine model. The letter designations depict the position of the section with respect to the AV graft placement. ...
5.
Bio Vascular Inc. Arterial Venous Grafts
Placement of the AV graft in the canine model. The letter designations depict the position of the section with respect to the AV graft placement. ...
6.
Bio Vascular Inc. Home
BioVascular Inc. is a privately held biotechnology company that develops drugs and devices for the control of intimal hyperplasia associated with vascular ...
7.
Bio Vascular Inc. Saratin
Saratin is a 12 kDa polypeptide originally identified as a component of leech saliva (Hirudo medicinalis) and currently produced as a recombinant protein in ...
8.
Bio Vascular Inc. Endovascular Procedures
The effect of Saratin on the endovascular healing of surgically-injured vessels was ... In this model, saratin was applied locally at the site of an open ...
9.
Bio Vascular Inc. Saratin
Saratin is a 12 kDa polypeptide originally identified as a component of leech saliva (Hirudo medicinalis) and currently produced as a recombinant protein in ...
10.